Genomma Lab Internacional SAB de CV
BMV:LABB

Watchlist Manager
Genomma Lab Internacional SAB de CV Logo
Genomma Lab Internacional SAB de CV
BMV:LABB
Watchlist
Price: 26.3 MXN 0.57% Market Closed
Market Cap: 26.8B MXN
Have any thoughts about
Genomma Lab Internacional SAB de CV?
Write Note

Intrinsic Value

The intrinsic value of one LABB stock under the Base Case scenario is 26.75 MXN. Compared to the current market price of 26.3 MXN, Genomma Lab Internacional SAB de CV is Undervalued by 2%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LABB Intrinsic Value
26.75 MXN
Undervaluation 2%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Genomma Lab Internacional SAB de CV

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for LABB cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about LABB?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Genomma Lab Internacional SAB de CV

Provide an overview of the primary business activities
of Genomma Lab Internacional SAB de CV.

What unique competitive advantages
does Genomma Lab Internacional SAB de CV hold over its rivals?

What risks and challenges
does Genomma Lab Internacional SAB de CV face in the near future?

Summarize the latest earnings call
of Genomma Lab Internacional SAB de CV.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Genomma Lab Internacional SAB de CV.

Provide P/S
for Genomma Lab Internacional SAB de CV.

Provide P/E
for Genomma Lab Internacional SAB de CV.

Provide P/OCF
for Genomma Lab Internacional SAB de CV.

Provide P/FCFE
for Genomma Lab Internacional SAB de CV.

Provide P/B
for Genomma Lab Internacional SAB de CV.

Provide EV/S
for Genomma Lab Internacional SAB de CV.

Provide EV/GP
for Genomma Lab Internacional SAB de CV.

Provide EV/EBITDA
for Genomma Lab Internacional SAB de CV.

Provide EV/EBIT
for Genomma Lab Internacional SAB de CV.

Provide EV/OCF
for Genomma Lab Internacional SAB de CV.

Provide EV/FCFF
for Genomma Lab Internacional SAB de CV.

Provide EV/IC
for Genomma Lab Internacional SAB de CV.

Show me price targets
for Genomma Lab Internacional SAB de CV made by professional analysts.

What are the Revenue projections
for Genomma Lab Internacional SAB de CV?

How accurate were the past Revenue estimates
for Genomma Lab Internacional SAB de CV?

What are the Net Income projections
for Genomma Lab Internacional SAB de CV?

How accurate were the past Net Income estimates
for Genomma Lab Internacional SAB de CV?

What are the EPS projections
for Genomma Lab Internacional SAB de CV?

How accurate were the past EPS estimates
for Genomma Lab Internacional SAB de CV?

What are the EBIT projections
for Genomma Lab Internacional SAB de CV?

How accurate were the past EBIT estimates
for Genomma Lab Internacional SAB de CV?

Compare the revenue forecasts
for Genomma Lab Internacional SAB de CV with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Genomma Lab Internacional SAB de CV and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Genomma Lab Internacional SAB de CV against its competitors.

Analyze the profit margins
(gross, operating, and net) of Genomma Lab Internacional SAB de CV compared to its peers.

Compare the P/E ratios
of Genomma Lab Internacional SAB de CV against its peers.

Discuss the investment returns and shareholder value creation
comparing Genomma Lab Internacional SAB de CV with its peers.

Analyze the financial leverage
of Genomma Lab Internacional SAB de CV compared to its main competitors.

Show all profitability ratios
for Genomma Lab Internacional SAB de CV.

Provide ROE
for Genomma Lab Internacional SAB de CV.

Provide ROA
for Genomma Lab Internacional SAB de CV.

Provide ROIC
for Genomma Lab Internacional SAB de CV.

Provide ROCE
for Genomma Lab Internacional SAB de CV.

Provide Gross Margin
for Genomma Lab Internacional SAB de CV.

Provide Operating Margin
for Genomma Lab Internacional SAB de CV.

Provide Net Margin
for Genomma Lab Internacional SAB de CV.

Provide FCF Margin
for Genomma Lab Internacional SAB de CV.

Show all solvency ratios
for Genomma Lab Internacional SAB de CV.

Provide D/E Ratio
for Genomma Lab Internacional SAB de CV.

Provide D/A Ratio
for Genomma Lab Internacional SAB de CV.

Provide Interest Coverage Ratio
for Genomma Lab Internacional SAB de CV.

Provide Altman Z-Score Ratio
for Genomma Lab Internacional SAB de CV.

Provide Quick Ratio
for Genomma Lab Internacional SAB de CV.

Provide Current Ratio
for Genomma Lab Internacional SAB de CV.

Provide Cash Ratio
for Genomma Lab Internacional SAB de CV.

What is the historical Revenue growth
over the last 5 years for Genomma Lab Internacional SAB de CV?

What is the historical Net Income growth
over the last 5 years for Genomma Lab Internacional SAB de CV?

What is the current Free Cash Flow
of Genomma Lab Internacional SAB de CV?

Discuss the annual earnings per share (EPS)
trend over the past five years for Genomma Lab Internacional SAB de CV.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Genomma Lab Internacional SAB de CV

Current Assets 12B
Cash & Short-Term Investments 1.2B
Receivables 7.2B
Other Current Assets 3.6B
Non-Current Assets 10B
PP&E 3.5B
Intangibles 5.5B
Other Non-Current Assets 921.2m
Current Liabilities 6.1B
Accounts Payable 1.8B
Accrued Liabilities 126.8m
Other Current Liabilities 4.2B
Non-Current Liabilities 5.3B
Long-Term Debt 4.9B
Other Non-Current Liabilities 362.5m
Efficiency

Earnings Waterfall
Genomma Lab Internacional SAB de CV

Revenue
16.8B MXN
Cost of Revenue
-6.2B MXN
Gross Profit
10.6B MXN
Operating Expenses
-7.1B MXN
Operating Income
3.4B MXN
Other Expenses
-2.1B MXN
Net Income
1.3B MXN

Free Cash Flow Analysis
Genomma Lab Internacional SAB de CV

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

LABB Profitability Score
Profitability Due Diligence

Genomma Lab Internacional SAB de CV's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive Revenue Growth Forecast
58/100
Profitability
Score

Genomma Lab Internacional SAB de CV's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

LABB Solvency Score
Solvency Due Diligence

Genomma Lab Internacional SAB de CV's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Low D/E
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
49/100
Solvency
Score

Genomma Lab Internacional SAB de CV's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LABB Price Targets Summary
Genomma Lab Internacional SAB de CV

Wall Street analysts forecast LABB stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LABB is 26.21 MXN with a low forecast of 15.15 MXN and a high forecast of 34.65 MXN.

Lowest
Price Target
15.15 MXN
42% Downside
Average
Price Target
26.21 MXN
0% Downside
Highest
Price Target
34.65 MXN
32% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for LABB?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for LABB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Genomma Lab Internacional SAB de CV Logo
Genomma Lab Internacional SAB de CV

Country

Mexico

Industry

Pharmaceuticals

Market Cap

24.9B MXN

Dividend Yield

3.01%

Description

Genomma Lab Internacional SAB de CV engages in the development, manufacturing and marketing of pharmaceutical, beauty and personal care products. The company is headquartered in Mexico City, Mexico, D.F.. The company went IPO on 2008-06-19. The firm is engaged in the development, distribution and marketing of a range of products within different brands, for such treatments as anti-acne, varicose vein, hair loss, sexual stimulation and influenza; as well as analgesics and antifungals. The Company’s product portfolio includes such brands as Asepxia, Cicatricure, Goicoechea, Bengue, Diabet TX, Genoprazol, Goicotabs, Shot B, SilkaMedic, Siluet 40, Nikzon, X Ray, Next, Touch Me, Lomecan V and QG5, among others. The firm is a parent of a number of controlled entities, which have operations established in Mexico, the United States, Peru, Chile, Ecuador and Honduras, among others. In June 2014, the Company acquired 50% stake in Grupo Comercial e Industrial Marzam SA de CV.

Contact

MEXICO, D.F.
Mexico City
Avenida Antonio Dovali Jaime, numero 70, torre C, piso 2, despacho A. Colonia Santa Fe. Delegacion Alvaro Obregon
+528007171305.0
www.genommalab.com

IPO

2008-06-19

Employees

2 067

Officers

Founder & Chairman of the Board
Lic. Rodrigo Alonso Herrera Aspra
Chief Executive Officer
Mr. Juan Marco Sparvieri
Executive VP of Finance & Administration and CFO
Engineer Antonio Zamora Galland
Head of Investor Relations
Ms. Christianne Ibáñez Garcia
EVP of Institutional Relations, Media, HR & Sustainability
Mr. Alejandro Bastón Patiño
Secretary
Mr. Efraan Tapia Cardova
Show More
Investor Relations Officer
Daniel Suarez Neria
Show Less

See Also

Discover More
What is the Intrinsic Value of one LABB stock?

The intrinsic value of one LABB stock under the Base Case scenario is 26.75 MXN.

Is LABB stock undervalued or overvalued?

Compared to the current market price of 26.3 MXN, Genomma Lab Internacional SAB de CV is Undervalued by 2%.

Back to Top